Marc Dunoyer - 07 Jun 2022 Form 4 Insider Report for Orchard Therapeutics plc

Role
Director
Signature
/s/ Frank Thomas, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
07 Jun 2022
Net transactions value
$0
Form type
4
Filing time
08 Jun 2022, 16:05:49 UTC
Previous filing
17 Jun 2021
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORTX Stock Option (Right to Buy) Award $0 +46,000 $0.000000 46,000 07 Jun 2022 Ordinary Shares 46,000 $0.4747 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the shares subject to this option vest upon the earlier to occur of June 7, 2023 or the date of the 2023 Annual General Meeting of the Company.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.